Ignite Creation Date:
2025-12-24 @ 5:44 PM
Ignite Modification Date:
2026-05-30 @ 2:22 PM
Study NCT ID:
NCT00088868
Status:
COMPLETED
Last Update Posted:
2012-03-15
First Post:
2004-08-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma
Sponsor:
National Institutes of Health Clinical Center (CC)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
040218
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |